Spearhead Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $952K | Sell |
|
|||||
|
2022
Q2 | $9.95M | Sell |
|
|||||
|
2022
Q1 | $13M | Sell |
|
|||||
|
2021
Q4 | $11.5M | Buy |
|
|||||
|
2021
Q3 | $8.91M | Buy |
|
|||||
|
2021
Q2 | $8.08M | Buy |
|
|||||
|
2021
Q1 | $7.6M | Buy |
|
|||||
|
2020
Q4 | $7.36M | Buy |
|
|||||
|
2020
Q3 | $5.48M | Buy |
|
|||||
|
2020
Q2 | $6.03M | Buy |
|
|||||
|
2020
Q1 | $4.4M | Sell |
|
|||||
|
2019
Q4 | $5.13M | Sell |
|
|||||
|
2019
Q3 | $4.45M | Buy |
|
|||||
|
2019
Q2 | $3.71M | Buy |
|
|||||
|
2019
Q1 | $3.58M | Buy |
|
|||||
|
2018
Q4 | $3.23M | Sell |
|
|||||
|
2018
Q3 | $3.46M | Buy |
|
|||||
|
2018
Q2 | $3.28M | Buy |
|
|||||
|
2018
Q1 | $3.08M | Buy |
|
|||||
|
2017
Q4 | $2.65M | Buy |
|